Talwin injection


|Talwin Talwin injection

Drugs search, click the first letter of a drug name:

| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home


Generic Name: pentazocine hydrochloride and naloxone hydrochloride

Talwin® Nx is intended for oral use only. Severe, potentially lethal, reactions may result from misuse of Talwin® Nx by injection either alone or in combination with other substances. (See DRUG ABUSE AND DEPENDENCE section.)

Talwin Description

Talwin Nx contains pentazocine hydrochloride, USP, equivalent to 50 mg base and is a member of the benzazocine series (also known as the benzomorphan series), and Naloxone hydrochloride, USP, equivalent to 0.5 mg base.

Talwin Nx is an analgesic for oral administration.

Chemically, pentazocine hydrochloride is 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride, a white, crystalline substance soluble in acidic aqueous solutions, and has the following structural formula:

Chemically, naloxone hydrochloride is Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, hydrochloride, (5α)-. It is a slightly off-white powder, and is soluble in water and dilute acids, and has the following structural formula:

Inactive Ingredients: Colloidal Silicon Dioxide, Dibasic Calcium Phosphate, D&C Yellow #10, FD&C Yellow #6, Magnesium Stearate, Microcrystalline Cellulose, Sodium Lauryl Sulfate, Starch.

Talwin - Clinical Pharmacology

Pentazocine is a potent analgesic which when administered orally in a 50 mg dose appears equivalent in analgesic effect to 60 mg (1 grain) of codeine. Onset of significant analgesia usually occurs between 15 and 30 minutes after oral administration, and duration of action is usually three hours or longer. Onset and duration of action and the degree of pain relief are related both to dose and the severity of pretreatment pain. Pentazocine weakly antagonizes the analgesic effects of morphine and meperidine; in addition, it produces incomplete reversal of cardiovascular, respiratory, and behavioral depression induced by morphine and meperidine. Pentazocine has about 1/50 the antagonistic activity of nalorphine. It also has sedative activity.

Pentazocine is well absorbed from the gastrointestinal tract. Concentrations in plasma coincide closely with the onset, duration, and intensity of analgesia; peak values occur 1 to 3 hours after oral administration. The half-life in plasma is 2 to 3 hours.

Pentazocine is metabolized in the liver and excreted primarily in the urine. Pentazocine passes into the fetal circulation.

Naloxone when administered orally at 0.5 mg has no pharmacologic activity. Naloxone hydrochloride administered parenterally at the same dose is an effective antagonist to pentazocine and a pure antagonist to narcotic analgesics.

Talwin Nx is a potent analgesic when administered orally. However, the presence of naloxone in Talwin Nx will prevent the effect of pentazocine if the product is misused by injection.

Studies in animals indicate that the presence of naloxone does not affect pentazocine analgesia when the combination is given orally. If the combination is given by injection the action of pentazocine is neutralized.

Indications and Usage for Talwin

Talwin® Nx is intended for oral use only. Severe, potentially lethal, reactions may result from misuse of Talwin® Nx by injection either alone or in combination with other substances. (See DRUG ABUSE AND DEPENDENCE section.)

Talwin Nx is indicated for the relief of moderate to severe pain.

Talwin Nx is indicated for oral use only.


Talwin Nx should not be administered to patients who are hypersensitive to either pentazocine or naloxone.

Talwin® Nx is intended for oral use only. Severe, potentially lethal, reactions may result from misuse of Talwin® Nx by injection either alone or in combination with other substances. (See DRUG ABUSE AND DEPENDENCE section.)


Drug Dependence

Pentazocine can cause a physical and psychological dependence. (See DRUG ABUSE AND DEPENDENCE.)

Head Injury and Increased Intracranial Pressure

As in the case of other potent analgesics, the potential of pentazocine for elevating cerebrospinal fluid pressure may be attributed to CO2 retention due to the respiratory depressant effects of the drug. These effects may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a preexisting increase in intracranial pressure. Furthermore, pentazocine can produce effects which may obscure the clinical course of patients with head injuries. In such patients, pentazocine must be used with extreme caution and only if its use is deemed essential.

Usage with Alcohol

Due to the potential for increased CNS depressants effects, alcohol should be used with caution in patients who are currently receiving pentazocine.

Patients Receiving Narcotics

Pentazocine is a mild narcotic antagonist. Some patients previously given narcotics, including methadone for the daily treatment of narcotic dependence, have experienced withdrawal symptoms after receiving pentazocine.

Certain Respiratory Conditions

Although respiratory depression has rarely been reported after oral administration of pentazocine, the drug should be administered with caution to patients with respiratory depression from any cause, severely limited respiratory reserve, severe bronchial asthma, and other obstructive respiratory conditions, or cyanosis.

Acute CNS Manifestations

Patients receiving therapeutic doses of pentazocine have experienced hallucinations (usually visual), disorientation, and confusion which have cleared spontaneously within a period of hours. The mechanism of this reaction is not known. Such patients should be very closely observed and vital signs checked. If the drug is reinstituted, it should be done with caution since these acute CNS manifestations may recur.


CNS Effect

Caution should be used when pentazocine is administered to patients prone to seizures; seizures have occurred in a few such patients in association with the use of pentazocine though no cause and effect relationship has been established.

Impaired Renal or Hepatic Function

Decreased metabolism of pentazocine by the liver in extensive liver disease may predispose to accentuation of side effects. Although laboratory tests have not indicated that pentazocine causes or increases renal or hepatic impairment, the drug should be administered with caution to patients with such impairment.

In prescribing pentazocine for long-term use, the physician should take precautions to avoid increases in dose by the patient.

Biliary Surgery

Narcotic drug products are generally considered to elevate biliary tract pressure for varying periods following their administration. Some evidence suggests that pentazocine may differ from other marketed narcotics in this respect (i.e., it causes little or no elevation in biliary tract pressures). The clinical significance of these findings, however, is not yet known.

Information for Patients

Since sedation, dizziness, and occasional euphoria have been noted, ambulatory patients should be warned not to operate machinery, drive cars, or unnecessarily expose themselves to hazards. Pentazocine may cause physical and psychological dependence when taken alone and may have additive CNS depressant properties when taken in combination with alcohol or other CNS depressants.

Myocardial Infarction

As with all drugs, pentazocine should be used with caution in patients with myocardial infarction who have nausea or vomiting.

Drug Interactions

Usage with Alcohol: See WARNINGS.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No long-term studies in animals to test for carcinogenesis have been performed with the components of Talwin Nx.

Pregnancy Category C

Animal reproduction studies have not been conducted with Talwin Nx. It is also not known whether Talwin Nx can cause fetal harm when administered to pregnant women or can affect reproduction capacity. Talwin Nx should be given to pregnant women only if clearly needed. However, animal reproduction studies with pentazocine have not demonstrated teratogenic or embryotoxic effects.

Labor and Delivery

Patients receiving pentazocine during labor have experienced no adverse effects other than those that occur with commonly used analgesics. Talwin Nx should be used with caution in women delivering premature infants. The effect of Talwin Nx on the mother and fetus, the duration of labor or delivery, the possibility that forceps delivery or other intervention or resuscitation of the newborn may be necessary, or the effect of Talwin Nx on the later growth, development, and functional maturation of the child are unknown at the present time.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Talwin Nx is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in pediatric patients below the age of 12 years have not been established.

Geriatric Use

Controlled clinical studies of Talwin Nx did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses or effectiveness in analgesic activity between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Adverse Reactions

Cardiovascular. Hypotension, tachycardia, syncope.

Respiratory. Rarely, respiratory depression.

Acute CNS Manifestations. Patients receiving therapeutic doses of pentazocine have experienced hallucinations (usually visual), disorientation, and confusion which have cleared spontaneously within a period of hours. The mechanism of this reaction is not known. Such patients should be closely observed and vital signs checked. If the drug is reinstituted it should be done with caution since these acute CNS manifestations may recur.

Other CNS Effects. Dizziness, lightheadedness, hallucinations, sedation, euphoria, headache, confusion, disorientation; infrequently weakness, disturbed dreams, insomnia, syncope, visual blurring and focusing difficulty, depression; and rarely tremor, irritability, excitement, tinnitus.

Autonomic. Sweating; infrequently flushing; and rarely chills.

Gastrointestinal. Nausea, vomiting, constipation, diarrhea, anorexia, rarely abdominal distress.

Allergic. Edema of the face; dermatitis, including pruritus; flushed skin, including plethora; infrequently rash, and rarely urticaria.

Ophthalmic. Visual blurring and focusing difficulty.

Hematologic. Depression of white blood cells (especially granulocytes), which is usually reversible, moderate transient eosinophilia.

Other. Headache, chills, insomnia, weakness, urinary retention, paresthesia, serious skin reactions, including erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

Drug Abuse and Dependence

Controlled Substance

Talwin Nx is a Schedule IV controlled substance.

There have been some reports of dependence and of withdrawal symptoms with orally administered pentazocine. Patients with a history of drug dependence should be under close supervision while receiving pentazocine orally. There have been rare reports of possible abstinence syndromes in newborns after prolonged use of pentazocine during pregnancy.

There have been instances of psychological and physical dependence on parenteral pentazocine in patients with a history of drug abuse and rarely, in patients without such a history. Abrupt discontinuance following the extended use of parenteral pentazocine has resulted in withdrawal symptoms.

In prescribing pentazocine for chronic use, the physician should take precautions to avoid increases in dose by the patient.

The amount of naloxone present in Talwin Nx (0.5 mg per tablet) has no action when taken orally and will not interfere with the pharmacologic action of pentazocine. However, this amount of naloxone given by injection has profound antagonistic action to narcotic analgesics.

Severe, even lethal, consequences may result from misuse of tablets by injection either alone or in combination with other substances, such as pulmonary emboli, vascular occlusion, ulceration and abscesses, and withdrawal symptoms in narcotic dependent individuals.

Talwin Nx contains an opioid antagonist, naloxone (0.5 mg). Naloxone is inactive when administered orally at this dose, and its inclusion in Talwin Nx is intended to curb a form of misuse of oral pentazocine. Parenterally, naloxone is an active narcotic antagonist. Thus, Talwin Nx has a lower potential for parenteral misuse than the previous oral pentazocine formulation Talwin® 50 (pentazocine hydrochloride tablets, USP). However, it is still subject to patient misuse and abuse by the oral route.



Clinical experience of overdosage with this oral medication has been insufficient to define the signs of this condition.


Oxygen, intravenous fluids, vasopressors, and other supportive measures should be employed as indicated. Assisted or controlled ventilation should also be considered. For respiratory depression due to overdosage or unusual sensitivity to pentazocine, parenteral naloxone is a specific and effective antagonist.

Talwin® Nx is intended for oral use only. Severe, potentially lethal, reactions may result from misuse of Talwin® Nx by injection either alone or in combination with other substances. (See DRUG ABUSE AND DEPENDENCE section.)

Talwin Dosage and Administration


The usual initial adult dose is 1 tablet every three or four hours. This may be increased to 2 tablets when needed. Total daily dosage should not exceed 12 tablets.

When anti-inflammatory or antipyretic effects are desired in addition to analgesia, aspirin can be administered concomitantly with this product.

Pediatric Patients

Since clinical experience in pediatric patients under 12 years of age is limited, administration of this product in this age group is not recommended.

Duration of Therapy

Patients with chronic pain who receive Talwin Nx orally for prolonged periods have only rarely been reported to experience withdrawal symptoms when administration was abruptly discontinued (see WARNINGS). Tolerance to the analgesic effect of pentazocine has also been reported only rarely. However, there is no long-term experience with the oral administration of Talwin Nx.

How is Talwin Supplied

Tablets (oblong), yellow, scored, each containing pentazocine hydrochloride equivalent to 50 mg base and naloxone hydrochloride equivalent to 0.5 mg base.

Bottles of 100 (NDC 0024-1951-04).

Store at 25° C (77° F); excursions permitted between 15°– 30° C (59° F to 86° F).

Manufactured for

Sanofi-Synthelabo Inc.
New York, NY 10016
by Searle Ltd.
Barceloneta, Puerto Rico 00617


Revised May 2003

Copyright, Sanofi-Synthelabo Inc. 1982, 2003

Talwin Nx (pentazocine hydrochloride and naloxone hydrochloride)
Product Code 0024-1951 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CIV
Name (Active Moiety) Type Strength
pentazocine hydrochloride (pentazocine) Active 50 MILLIGRAM  In 1 TABLET
naloxone hydrochloride (naloxone) Active 0.5 MILLIGRAM  In 1 TABLET
Colloidal Silicon Dioxide Inactive  
Dibasic Calcium Phosphate Inactive  
D&C Yellow #10 Inactive  
FD&C Yellow #6 Inactive  
Magnesium Stearate Inactive  
Microcrystalline Cellulose Inactive  
Sodium Lauryl Sulfate Inactive  
Starch Inactive  
Characteristic Appearance Characteristic Appearance
Color YELLOW (YELLOW) Score 2
Shape OVAL (CAPSULE-SHAPED) Symbol true
Imprint Code T;51 Coating false
Size 16mm
# NDC Package Description Multilevel Packaging
1 0024-1951-04 100 TABLET In 1 BOTTLE None

Revised: 03/2007

Where can I get more information about Talwin Talwin injection ? We recommend to use www.Drugs.com

Typical mistypes for Talwin Talwin injection
ralwin talwin injection, falwin talwin injection, galwin talwin injection, yalwin talwin injection, 6alwin talwin injection, 5alwin talwin injection, tzlwin talwin injection, tslwin talwin injection, twlwin talwin injection, tqlwin talwin injection, takwin talwin injection, tapwin talwin injection, taowin talwin injection, talqin talwin injection, talain talwin injection, talsin talwin injection, talein talwin injection, tal3in talwin injection, tal2in talwin injection, talwun talwin injection, talwjn talwin injection, talwkn talwin injection, talwon talwin injection, talw9n talwin injection, talw8n talwin injection, talwib talwin injection, talwim talwin injection, talwij talwin injection, talwih talwin injection, talwin ralwin injection, talwin falwin injection, talwin galwin injection, talwin yalwin injection, talwin 6alwin injection, talwin 5alwin injection, talwin tzlwin injection, talwin tslwin injection, talwin twlwin injection, talwin tqlwin injection, talwin takwin injection, talwin tapwin injection, talwin taowin injection, talwin talqin injection, talwin talain injection, talwin talsin injection, talwin talein injection, talwin tal3in injection, talwin tal2in injection, talwin talwun injection, talwin talwjn injection, talwin talwkn injection, talwin talwon injection, talwin talw9n injection, talwin talw8n injection, talwin talwib injection, talwin talwim injection, talwin talwij injection, talwin talwih injection, talwin talwin unjection, talwin talwin jnjection, talwin talwin knjection, talwin talwin onjection, talwin talwin 9njection, talwin talwin 8njection, talwin talwin ibjection, talwin talwin imjection, talwin talwin ijjection, talwin talwin ihjection, talwin talwin inhection, talwin talwin innection, talwin talwin inmection, talwin talwin inkection, talwin talwin iniection, talwin talwin inuection, talwin talwin injwction, talwin talwin injsction, talwin talwin injdction, talwin talwin injrction, talwin talwin inj4ction, talwin talwin inj3ction, talwin talwin injextion, talwin talwin injevtion, talwin talwin injeftion, talwin talwin injedtion, talwin talwin injecrion, talwin talwin injecfion, talwin talwin injecgion, talwin talwin injecyion, talwin talwin injec6ion, talwin talwin injec5ion, talwin talwin injectuon, talwin talwin injectjon, talwin talwin injectkon, talwin talwin injectoon, talwin talwin inject9on, talwin talwin inject8on, talwin talwin injectiin, talwin talwin injectikn, talwin talwin injectiln, talwin talwin injectipn, talwin talwin injecti0n, talwin talwin injecti9n, talwin talwin injectiob, talwin talwin injectiom, talwin talwin injectioj, talwin talwin injectioh, alwin talwin injection, tlwin talwin injection, tawin talwin injection, talin talwin injection, talwn talwin injection, talwi talwin injection, talwin talwin injection, talwin talwin injection, talwin alwin injection, talwin tlwin injection, talwin tawin injection, talwin talin injection, talwin talwn injection, talwin talwi injection, talwin talwininjection, talwin talwin njection, talwin talwin ijection, talwin talwin inection, talwin talwin injction, talwin talwin injetion, talwin talwin injecion, talwin talwin injecton, talwin talwin injectin, talwin talwin injectio, atlwin talwin injection, tlawin talwin injection, tawlin talwin injection, taliwn talwin injection, talwni talwin injection, talwi n talwin injection, talwin talwin injection, talwin t alwin injection, talwin atlwin injection, talwin tlawin injection, talwin tawlin injection, talwin taliwn injection, talwin talwni injection, talwin talwi ninjection, talwin talwini njection, talwin talwin nijection, talwin talwin ijnection, talwin talwin inejction, talwin talwin injcetion, talwin talwin injetcion, talwin talwin injeciton, talwin talwin injectoin, talwin talwin injectino, ttalwin talwin injection, taalwin talwin injection, tallwin talwin injection, talwwin talwin injection, talwiin talwin injection, talwinn talwin injection, talwin talwin injection, talwin talwin injection, talwin ttalwin injection, talwin taalwin injection, talwin tallwin injection, talwin talwwin injection, talwin talwiin injection, talwin talwinn injection, talwin talwin injection, talwin talwin iinjection, talwin talwin innjection, talwin talwin injjection, talwin talwin injeection, talwin talwin injecction, talwin talwin injecttion, talwin talwin injectiion, talwin talwin injectioon, talwin talwin injectionn, etc.

© Copyright by drug-information.ru 2001-2019. All rights reserved